-
公开(公告)号:US11572564B2
公开(公告)日:2023-02-07
申请号:US15018736
申请日:2016-02-08
Applicant: Genomatica, Inc.
Inventor: Wei Niu
Abstract: The invention provides non-naturally occurring microbial organisms comprising a 1,4-butanediol (BDO), 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine pathway comprising at least one exogenous nucleic acid encoding a BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine pathway enzyme expressed in a sufficient amount to produce BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine and further optimized for expression of BDO. The invention additionally provides methods of using such microbial organisms to produce BDO, 4-hydroxybutyryl-CoA, 4-hydroxybutanal or putrescine.
-
公开(公告)号:US20230037234A1
公开(公告)日:2023-02-02
申请号:US17780421
申请日:2020-11-25
Applicant: Genomatica, Inc.
Inventor: Jingyi Li , Pierre DeWals , Andreas Schirmer , Sankha Ghatak , David Ryan Georgianna
Abstract: The invention relates to engineered microorganisms (e.g., E. coli) and associated improvements for increasing the production cannabinoids (e.g. CBGA) or precursors or derivatives thereof.
-
公开(公告)号:US20220348890A1
公开(公告)日:2022-11-03
申请号:US17605499
申请日:2020-04-24
Applicant: Genomatica, Inc.
Inventor: Amit M. Shah , Harish Nagarajan , Joseph Roy Warner , Russell Scott Komor
Abstract: Disclosed are transaminase (TA) enzymes and nucleic acids encoding them. In some cases, the transaminase enzymes are non-natural, engineered transaminases. Also disclosed are biosynthetic methods and engineered microorganisms that enhance or improve the biosynthesis of 6-aminocaproate, hexamethylenediamine, caproic acid, caprolactone, or caprolactam. The engineered microorganisms include exogenous TA and in some cases engineered TA.
-
公开(公告)号:US20220325254A1
公开(公告)日:2022-10-13
申请号:US17697504
申请日:2022-03-17
Applicant: Genomatica, Inc.
Inventor: Kevin Hoff , Cara Ann Tracewell , Kui Chan , Amit Shah , Joseph Warner , Michael Noble
IPC: C12N9/02
Abstract: The invention provides polypeptides and encoding nucleic acids of aldehyde dehydrogenase variants. The invention also provides cells expressing aldehyde dehydrogenase variants. The invention further provides methods for producing 3-hydroxybutyraldehyde (3-HBal) and/or 1,3-butanediol (1,3-BDO), or an ester or amide thereof, comprising culturing cells expressing an aldehyde dehydrogenase variant or using lysates of such cells. The invention additional provides methods for producing 4-hydroxybutyraldehyde (4-HBal) and/or 1,4-butanediol (1,4-BDO), or an ester or amide thereof, comprising culturing cells expressing an aldehyde dehydrogenase variant or using lysates of such cells.
-
公开(公告)号:US20220315969A1
公开(公告)日:2022-10-06
申请号:US17616842
申请日:2020-06-05
Applicant: Genomatica Inc.
Inventor: Michael Angus Noble , Russell Scott Komor
Abstract: Described herein are olivetolic acid cyclases (OAC) including non-natural variants capable of forming a 2,4-dihydroxy-6-alkylbenzoic acid from a 3,5,7-trioxoacyl-CoA or a 3,5,7-trioxocarboxylate substrate. In some examples, the non-natural OAC is capable of forming a 2,4-dihydroxy-6-alkylbenzoic acid from a 3,5,7-trioxoacyl-CoA or a 3,5,7-trioxocarboxylate substrate at a greater rate. In some examples, the non-natural OAC has a higher affinity for a 3,5,7-trioxoacyl-CoA or a 3,5,7-trioxocarboxylate substrate, as compared to the wild type OAC. The non-natural OAC can be used with olivetol synthase (OLS) to form the 2,4-dihydroxy-6-alkylbenzoic acid from malonyl-CoA and acyl-CoA through to a 3,5,7-trioxoacyl-CoAintermediate. The non-natural OAC (and OLS) can be expressed in an engineered cell having a pathway to form cannabinoids, which include CBGA, its analogs and derivatives. CBGA can be used for the preparation of cannabigerol (CBG), which can be used in therapeutic compositions.
-
公开(公告)号:US20220259623A1
公开(公告)日:2022-08-18
申请号:US17508400
申请日:2021-10-22
Applicant: Genomatica, Inc.
Inventor: Andreas W. SCHIRMER , Mathew A. RUDE , Shane A. BRUBAKER
IPC: C12P7/64 , C12N9/02 , C10L1/02 , C12N9/88 , C12P7/04 , C12P7/24 , C12P7/6409 , C12P7/6436 , C12P7/649 , C12P5/02
Abstract: Compositions and methods for producing aldehydes, alkanes, and alkenes are described herein. The aldehydes, alkanes, and alkenes can be used in biofuels.
-
公开(公告)号:US11365432B2
公开(公告)日:2022-06-21
申请号:US16573796
申请日:2019-09-17
Applicant: Genomatica, Inc.
Inventor: Liang Wu , Axel Christoph Trefzer , Stefaan Marie Andre De Wildeman , Marco Alexander Van Den Berg
Abstract: The present invention relates to a method for preparing an adipate ester or thioester. The invention further relates to a method for preparing adipic acid from said ester or thioester. Further the invention provides a number of methods for preparing an intermediate for said ester or thioester. Further the invention relates to a method for preparing 6-amino caproic acid (6-ACA), a method for preparing 5-formyl valeric acid (5-FVA), and a method for preparing caprolactam. Further, the invention relates to a host cell for use in a method according to the invention.
-
公开(公告)号:US20220127649A1
公开(公告)日:2022-04-28
申请号:US17427019
申请日:2020-01-30
Applicant: Genomatica, Inc.
Inventor: Michael A. Noble , Jonathan Moore , Jingyi Li , Anna Lechner
Abstract: The invention provides non-natural microbial organisms containing enzymatic pathways and/or metabolic modifications for enhancing synthesis of olivetolic acid, olivetolic acid derivatives and/or cannabinoids.
-
公开(公告)号:US20220098133A1
公开(公告)日:2022-03-31
申请号:US17494303
申请日:2021-10-05
Applicant: Genomatica, Inc.
Inventor: Haibo WANG
IPC: C07C33/035 , C07H15/10
Abstract: The disclosure relates to the field of specialty chemicals. In particular, the disclosure provides novel 1,3-fatty-diol compounds and derivatives thereof which are useful e.g., in the production of personal care products, surfactants, detergents, polymers, paints, coatings, and as emulsifiers, emollients, and thickeners in cosmetics and foods, as industrial solvents and plasticizers, etc.
-
公开(公告)号:US20210355071A1
公开(公告)日:2021-11-18
申请号:US17308864
申请日:2021-05-05
Applicant: Genomatica, Inc.
Inventor: Zhihao HU , Fernando VALLE
IPC: C07C69/533 , C12N1/20 , C12N1/16 , C12N1/14 , C12N1/12 , C07C69/34 , C07C69/52 , C10L1/02 , C10L1/19 , C11C3/00 , C12P7/64 , C12N9/02 , C12N9/10 , C12N9/16 , C12N9/00
Abstract: Genetically engineered cells and microorganisms are provided that produce products from the fatty acid biosynthetic pathway (fatty acid derivatives), as well as methods of their use. The products are particularly useful as biofuels.
-
-
-
-
-
-
-
-
-